Sg Americas Securities, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	SELL	$144.95 - $152.29 $1.36 Million - $1.43 Million	-9,396 Reduced 46.56%	10,786 $1.63 Million
Q2 2022 Jul 29, 2022	BUY	$83.14 - $145.99 $724,481 - $1.27 Million	8,714 Added 75.99%	20,182 $2.94 Million
Q1 2022 Apr 29, 2022	SELL	$110.08 - $142.92 $903,756 - $1.17 Million	-8,210 Reduced 41.72%	11,468 $1.36 Million
Q4 2021 Feb 07, 2022	SELL	$99.73 - $148.48 $33,509 - $49,889	-336 Reduced 1.68%	19,678 $2.71 Million
Q3 2021 Nov 01, 2021	BUY	$98.85 - $138.91 $1.06 Million - $1.49 Million	10,709 Added 115.09%	20,014 $2.78 Million
Q2 2021 Aug 12, 2021	BUY	$65.78 - $105.02 $31,048 - $49,569	472 Added 5.34%	9,305 $903,000
Q1 2021 May 13, 2021	SELL	$64.07 - $91.75 $116,799 - $167,260	-1,823 Reduced 17.11%	8,833 $604,000
Q4 2020 Feb 04, 2021	SELL	$65.07 - $98.24 $216,487 - $326,844	-3,327 Reduced 23.79%	10,656 $913,000
Q3 2020 Nov 09, 2020	BUY	$59.04 - $77.95 $369,118 - $487,343	6,252 Added 80.87%	13,983 $909,000
Q2 2020 Jul 20, 2020	SELL	$29.01 - $74.23 $641,033 - $1.64 Million	-22,097 Reduced 74.08%	7,731 $565,000
Q1 2020 Apr 30, 2020	BUY	$27.51 - $57.29 $759,165 - $1.58 Million	27,596 Added 1236.38%	29,828 $1.02 Million
Q4 2019 Jan 28, 2020	BUY	$40.86 - $57.65 $91,199 - $128,674	2,232 New	2,232 $122,000
Q2 2019 Jul 29, 2019	SELL	$39.79 - $67.01 $445,488 - $750,243	-11,196 Closed	0 $0
Q1 2019 Apr 29, 2019	SELL	$34.52 - $53.29 $86,334 - $133,278	-2,501 Reduced 18.26%	11,196 $576,000
Q4 2018 Feb 01, 2019	BUY	$29.75 - $42.9 $407,485 - $587,601	13,697 New	13,697 $507,000
Q3 2018 Nov 06, 2018	SELL	$32.79 - $43.0 $158,244 - $207,518	-4,826 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$23.62 - $42.29 $113,990 - $204,091	4,826 New	4,826 $191,000

Others Institutions Holding BHVN

# of Institutions

Shares Held

792K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account